Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
465 |
|
| Actual shortage: | 53 (11%) | |
| Anticipated shortage: | 21 (5%) | |
| Avoided shortage: | 9 (2%) | |
| Resolved: | 382 (82%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
51 (10%) |
|
Overdue reports |
12 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-03-16 | 2024-03-02 | 187295 |
| MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-03-16 | 2023-05-04 | 187300 |
| FUROSEMIDE | 80MG | TABLET | Resolved | 2023-03-16 | 2023-07-06 | 187306 |
| FUROSEMIDE | 20MG | TABLET | Resolved | 2023-03-16 | 2023-07-06 | 187311 |
| ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-06-22 | 2023-08-08 | 196099 |
| ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-06-22 | 2023-09-06 | 196102 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2023-06-27 | 2023-11-13 | 196716 |
| ATENOLOL | 50MG | TABLET | Resolved | 2023-06-27 | 2023-10-10 | 196720 |
| LEFLUNOMIDE | 10MG | TABLET | Resolved | 2023-07-05 | 2023-09-25 | 197620 |
| LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-07-05 | 2023-11-06 | 197624 |
| MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-07-05 | 2024-01-30 | 197632 |
| CEPHALEXIN | 250MG | TABLET | Resolved | 2023-07-14 | 2024-03-08 | 198742 |
| CEPHALEXIN | 500MG | TABLET | Resolved | 2023-07-14 | 2023-12-26 | 198745 |
| SILDENAFIL | 100MG | TABLET | Resolved | 2023-07-17 | 2023-09-19 | 198785 |
| OLANZAPINE | 15MG | TABLET | Resolved | 2023-07-17 | 2023-09-05 | 198789 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2023-07-17 | 2023-09-05 | 198795 |
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-07-18 | 2023-09-25 | 198904 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-07-18 | 2023-08-28 | 198907 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-07-18 | 2023-11-06 | 198936 |
| FUROSEMIDE | 20MG | TABLET | Resolved | 2023-07-31 | 2023-10-23 | 200426 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |